Implementation of the new Patented Medicines Prices Review Board regulations that were due to come into force on January 1, 2021 have been delayed by six-month. The coming-into-force was previously delayed from July 1st and the regulations have been subject to several legal challenges.

See earlier posts:

• October 23, 2020 – The Patented Medicine Prices Review Board published updated guidelines.
• June 19, 2020 – The Patented Medicines Prices Review Board has released revised proposed guidelines for consultation until July 20, 2020.

Globe and Mail: “Regulations to lower drug prices in Canada delayed yet again after industry cites COVID-19 concerns“